Drug Discovery & Development in Pharmaceutical & Life Science

This evidence set isolates Drug Discovery & Development deployments within Pharmaceutical & Life Science. The records below identify the implementing organization, technology and vendor when reported, source-reported results, cited source, and missing evidence explicitly.

Documented Drug Discovery & Development implementations in Pharmaceutical & Life Science

B

Bristol Myers Squibb

Bristol Myers Squibb accelerates protein degradation drug discovery with AI and machine learning

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics

Reported result:

~3% of ~20,000 human protein-coding genes Druggable Proteome Coverage (Current)

Deployment timeframe:

Not reported by source

Technology:

Machine Learning & Predictive Analytics

Vendor:

Not available in record

Cited source: www.bms.comSource link checked Jul 28, 2026Automated evidence gate passed

P

Pfizer

Pfizer deploys AI across R&D and commercial operations to cut billions in costs and boost productivity

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:

Billions in R&D and admin spending Cost Savings

Deployment timeframe:

Not reported by source

Technology:

Large Language Models & Generative AI

Vendor:

Not available in record

Cited source: www.biospace.comSource link checked Jul 28, 2026Automated evidence gate passed

A

AstraZeneca

AstraZeneca uses BostonGene AI foundation model to predict patient safety and efficacy in early oncology trials

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics

Reported result:

Not reported by source

Deployment timeframe:

Not reported by source

Technology:

Machine Learning & Predictive Analytics

Vendor:

Not available in record

Cited source: www.appliedclinicaltrialsonline.comSource link checked Jul 28, 2026Automated evidence gate passed

P

Pfizer

Pfizer cuts COVID-19 vaccine development from 8-10 years to 269 days using AWS AI and cloud infrastructure

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:

269 days (vs. 8-10 year typical) COVID-19 Vaccine Development Time

Deployment timeframe:

Not reported by source

Technology:

Large Language Models & Generative AI

Vendor:

Not available in record

Cited source: aws.amazon.comSource link checked Jul 28, 2026Automated evidence gate passed

I

Insilico Medicine

Insilico Medicine's AI-generated drug INS018_055 enters Phase II human clinical trials for idiopathic pulmonary fibrosis

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:

~3 years (2020 discovery to 2023 Phase II) Drug Development Timeline to Phase II

Deployment timeframe:

Not reported by source

Technology:

Large Language Models & Generative AI

Vendor:

Not available in record

Cited source: www.cnbc.comSource link checked Jul 28, 2026Automated evidence gate passed

M

Merck & Co.

Merck deploys GPTeal enterprise AI platform reaching 50,000+ employees across pharma R&D

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:

50,000+ employees (67% of workforce) Active Monthly Users

Deployment timeframe:

Not reported by source

Technology:

Large Language Models & Generative AI

Vendor:

Not available in record

Cited source: intuitionlabs.aiSource link checked Jul 28, 2026Automated evidence gate passed

R

Relay Therapeutics

Relay Therapeutics AI platform drives 81% tumor reduction in breast cancer Phase 3 trial

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics

Reported result:

81% of participants Tumor Size Reduction Rate

Deployment timeframe:

Not reported by source

Technology:

Machine Learning & Predictive Analytics

Vendor:

Not available in record

Cited source: cen.acs.orgSource link checked Jul 28, 2026Automated evidence gate passed

A

AstraZeneca

AstraZeneca's MILTON AI Predicts 1,091 Diseases Before Diagnosis Using UK Biobank Genomic Data

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics

Reported result:

1,091 Diseases Predicted at High Accuracy (AUC > 0.7)

Deployment timeframe:

Not reported by source

Technology:

Machine Learning & Predictive Analytics

Vendor:

Not available in record

Cited source: www.sandeepanand.inSource link checked Jul 28, 2026Automated evidence gate passed

B

Bayer

Bayer reduces manual adverse event review burden with AI-powered pharmacovigilance detection on Amazon SageMaker

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics

Reported result:

170 milliseconds average Real-Time API Response Time

Deployment timeframe:

Not reported by source

Technology:

Machine Learning & Predictive Analytics

Vendor:

Not available in record

Cited source: aws.amazon.comSource link checked Jul 28, 2026Automated evidence gate passed

Insilico Medicine

Insilico Medicine discovers IPF drug candidate ISM001-055 in 18 months for $2M using generative AI

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:

18 months Time to Phase 1 Readiness

Deployment timeframe:

Not reported by source

Technology:

Large Language Models & Generative AI

Vendor:

Insilico Medicine

Cited source: www.fiercebiotech.comSource link checked Jul 28, 2026Automated evidence gate passed

I

Insilico Medicine

Insilico Medicine's Generative AI Platform Designs TNIK Inhibitor That Achieves Positive Phase 2a Results for IPF in 18-Month Discovery Timeline

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:

+98.4 mL vs. –62.3 mL FVC Improvement vs. Placebo (60mg dose)

Deployment timeframe:

Not reported by source

Technology:

Large Language Models & Generative AI

Vendor:

Not available in record

Cited source: insilico.comSource link checked Jul 28, 2026Automated evidence gate passed

I

Insilico Medicine

Insilico Medicine reaches Phase 2a clinical milestone with generative AI-designed TNIK inhibitor for IPF in under 30 months

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:

Under 30 months Time to Phase 1 Clinical Success

Deployment timeframe:

Not reported by source

Technology:

Large Language Models & Generative AI

Vendor:

Not available in record

Cited source: communities.springernature.comSource link checked Jul 28, 2026Automated evidence gate passed

A

AstraZeneca

AstraZeneca cuts protocol authoring time 85% with Modella AI multimodal models in oncology R&D

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:

85% Protocol Authoring Time Reduction

Deployment timeframe:

Not reported by source

Technology:

Large Language Models & Generative AI

Vendor:

Not available in record

Cited source: www.ainvest.comSource link checked Jul 28, 2026Automated evidence gate passed

P

Pfizer

Pfizer saves 16,000 scientist hours annually and cuts infrastructure costs 55% with AWS generative AI for drug development

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:

16,000 hours Scientist Search Time Saved Annually

Deployment timeframe:

Not reported by source

Technology:

Large Language Models & Generative AI

Vendor:

Not available in record

Cited source: aws.amazon.comSource link checked Jul 28, 2026Automated evidence gate passed

I

Insilico Medicine

Insilico Medicine cuts drug discovery timeline to 12-18 months with generative AI platform Chemistry42, advancing ISM3412 cancer drug to Phase 1 trial

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:

12–18 months (vs. 2.5–4 years traditional) Discovery Timeline (project initiation to PCC)

Deployment timeframe:

Not reported by source

Technology:

Large Language Models & Generative AI

Vendor:

Not available in record

Cited source: www.news-medical.netSource link checked Jul 28, 2026Automated evidence gate passed

S

Sumitomo Dainippon Pharma

Sumitomo Dainippon Pharma advances AI-designed OCD drug DSP-1181 to clinical trial in 12 months

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics

Reported result:

12 months (vs. ~5 years) Discovery to Clinical Trial

Deployment timeframe:

Not reported by source

Technology:

Machine Learning & Predictive Analytics

Vendor:

Not available in record

Cited source: www.intuitionlabs.aiSource link checked Jul 28, 2026Automated evidence gate passed

B

Bristol Myers Squibb

Bristol Myers Squibb's 'predict-first' AI approach validates 100% of small molecule programs before lab synthesis

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics

Reported result:

100% (up from 5% in 2021) Small Molecule Programs Using AI Pre-Synthesis

Deployment timeframe:

Not reported by source

Technology:

Machine Learning & Predictive Analytics

Vendor:

Not available in record

Cited source: www.pharmavoice.comSource link checked Jul 28, 2026Automated evidence gate passed

B

Bristol Myers Squibb

Bristol Myers Squibb accelerates drug development pipeline with Accenture GenAI

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:

Drug Development Pipeline Focus Area

Deployment timeframe:

Not reported by source

Technology:

Large Language Models & Generative AI

Vendor:

Not available in record

Cited source: AccentureSource link checked Jul 28, 2026Automated evidence gate passed